loader
Please Wait
Applying Filters...
menu
    • menu

    Setid D6e64824 De98 4fef A320 35212e28c6a3 Applno 21908 Form Capsule Oral Dosage 8mcg - Drug Product Composition: Lubiprostone

    Menu

    Lubiprostone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 577,102Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21908 / DOSAGE - CAPSULE;ORAL - 8MCG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    lubiprostone(UNII: 7662KG2R6K)
    (lubiprostone - UNII:7662KG2R6K)     		lubiprostone8ug

    Inactive Ingredients

    Ingredient Name
    Par Pharmaceutical, Inc.
    Bryant Ranch Prepack
    Takeda Pharmaceuticals America, Inc.
    Avera McKennan Hospital
    1,4-SORBITAN(AV0YTZ4E6J)   
    D&C yellow no. 10(35SW5USQ3G) 
    FD&C red no. 40(WZB9127XOA) 
    ferric oxide red(1K09F3G675) 
    FERROSOFERRIC OXIDE(XM0M87F357)   
    gelatin(2G86QN327L)  
    GELATIN, UNSPECIFIED(2G86QN327L)  
    medium-chain triglycerides(C9H2L21V7U)
    POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)   
    Polyvinyl Acetate Phthalate(58QVG85GW3)   
    PROPYLENE GLYCOL(6DC9Q167V3)   
    sorbitol(506T60A25R)
    titanium dioxide(15FIX9V2JP) 
    water(059QF0KO0R)